Cat. No. | Product name | CAS No. |
DC11854 |
IDX899
A novel potent, selective HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with EC50 of 1, 1.3, 2.8 and 11 nM for WT, K103N, Y181C and K103N/Y181C, respectively. |
1018450-26-4 |
DC9029 |
Abacavir
Abacavir is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. |
136470-78-5 |
DC7058 |
Amprenavir
Amprenavir (Agenerase) is a HIV protease inhibitor(Ki=0.6 nM) used to treat HIV infection. |
161814-49-9 |
DC3150 |
Atazanavir
Featured
Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM. |
198904-31-3 |
DC9480 |
Atazanavir (sulfate)
Atazanavir sulfate is a sulfate salt form of atazanavir that is an highly potent HIV-1 protease inhibitor. |
229975-97-7 |
DC10890 |
Bictegravir
Featured
Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM. |
1611493-60-7 |
DC9700 |
BMS-707035
Featured
BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity. |
729607-74-3 |
DC2046 |
Cobicistat (GS-9350)
Featured
Cobicistat (GS-9350) is a potent and selective inhibitor of CYP3A with IC50 of 30-285 nM. |
1004316-88-4 |
DC8908 |
Darunavir ethanolate
Featured
Darunavir ethanolate is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2). |
635728-49-3 |
DC11352 |
Delavirdine (mesylate)
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that selectively inhibits HIV-1 reverse transcriptase over DNA polymerase α and δ in vitro (IC50s = 0.26, 440, and >550 μM, respectively). |
147221-93-0 |
DC8897 |
Delavirdine
Delavirdine(U 90152) is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI). |
136817-59-9 |
DC7273 |
Dolutegravir
Featured
Dolutegravir (DTG, GSK1349572) is an integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. |
1051375-16-6 |
DC10250 |
Dolutegravir Sodium
Featured
Dolutegravir is a HIV integrase inhibitor with IC50 of 2.7 nM. |
1051375-19-9 |
DC9308 |
Doravirine (MK-1439)
Featured
Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor. |
1338225-97-0 |
DCAPI1479 |
Efavirenz
Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip |
154598-52-4 |
DC5902 |
Emtricitabine
Featured
Emtricitabine is a nucleoside analogue which inhibits the reverse nucleoside transcriptase enzyme. Structurally this antiviral agent is similar to Lamivudine. This agent is effective at targeting HIV and HBV viruses since these viruses replicate in a reve |
143491-57-0 |
DC4234 |
Etravirine
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1). |
269055-15-4 |
DCAPI1505 |
Darunavir
Featured
Darunavir(TMC114) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2) . |
206361-99-1 |
DC9476 |
NBD-556
Featured
NBD-556 is small molecule mimetic of CD4, NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding. |
333353-44-9 |
DC9477 |
NBD-557
NBD-557 is a potentially HIV-1 inhibitor. |
333352-59-3 |
DC10355 |
Nelfinavir
Featured
Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection. |
159989-64-7 |
DC9474 |
Nelfinavir (Mesylate)
Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection. |
159989-65-8 |